| Followers | 4045 |
| Posts | 152978 |
| Boards Moderated | 3 |
| Alias Born | 08/05/2009 |
Tuesday, December 26, 2023 8:46:18 AM
Recent SXTP News
- 60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis • GlobeNewswire Inc. • 05/26/2026 12:02:00 PM
- 60 Degrees Pharmaceuticals Announces First Quarter 2026 Results • GlobeNewswire Inc. • 05/15/2026 12:42:00 PM
- 60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website • GlobeNewswire Inc. • 04/15/2026 12:02:00 PM
- 60 Degrees Pharmaceuticals Announces 2025 Annual Results • GlobeNewswire Inc. • 03/31/2026 11:01:00 AM
- 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract • GlobeNewswire Inc. • 03/18/2026 12:01:00 PM
- 60 Degrees Pharmaceuticals reports three cures in babesiosis expanded access trial • IH Market News • 03/11/2026 03:13:11 PM
- 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial • GlobeNewswire Inc. • 03/11/2026 11:24:00 AM
- 60 Degrees Pharmaceuticals shares slide after unveiling GoodRx collaboration • IH Market News • 02/02/2026 04:07:40 PM
- 60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership • GlobeNewswire Inc. • 02/02/2026 01:01:00 PM
- 60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use • GlobeNewswire Inc. • 01/28/2026 01:01:00 PM
- 60 Degrees Pharmaceuticals shares slide after Nasdaq flags delisting risk • IH Market News • 01/26/2026 03:44:40 PM
- 60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention • GlobeNewswire Inc. • 01/22/2026 01:01:00 PM
- 60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio • GlobeNewswire Inc. • 01/15/2026 01:01:00 PM
- 60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State • GlobeNewswire Inc. • 12/29/2025 01:01:00 PM
- 60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026 • GlobeNewswire Inc. • 12/11/2025 01:01:00 PM
- 60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine • GlobeNewswire Inc. • 11/21/2025 01:01:00 PM
- 60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results • GlobeNewswire Inc. • 11/13/2025 06:51:00 PM
- 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/31/2025 01:00:00 PM
- 60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study • GlobeNewswire Inc. • 10/15/2025 11:14:00 AM
- 60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study • GlobeNewswire Inc. • 10/09/2025 11:04:00 AM
- 60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2025 12:02:00 PM
- 60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 08/21/2025 12:31:00 PM
- 60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis • GlobeNewswire Inc. • 08/19/2025 12:54:00 PM
- 60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results • GlobeNewswire Inc. • 08/13/2025 08:14:32 PM
- 60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria • GlobeNewswire Inc. • 07/17/2025 12:01:10 PM

